Translating this platform to PHLDA1^high CAF-rich pancreatic tumors could normalize the microenvironment, attenuate CAF-mediated immunosuppression, and potentiate the efficacy of PHLDA1-targeted therapies and immune checkpoint blockade. This evidence concerns the gene PHLDA1 and pancreatic neoplasm.